Chen, Yao-Tseng

Publications

Sort by

Co-Author Network

selected publications

RHAMM^B-mediated bifunctional nanotherapy targeting Bcl-xL and mitochondria for pancreatic neuroendocrine tumor treatment. Molecular therapy oncolytics. 2021 Academic Article GET IT
Times cited: 7
High interobserver variability and frequent overdiagnosis of dysplasia in fundic gland polyps can be improved by detecting atypia on the surface epithelium and an abrupt transition to non-neoplastic cells. Histopathology. 2021 Academic Article GET IT
High levels of truncated RHAMM cooperate with dysfunctional p53 to accelerate the progression of pancreatic cancer. Cancer letters. 2021 Academic Article GET IT
Times cited: 15
Classifying Lung Neuroendocrine Neoplasms through MicroRNA Sequence Data Mining. Cancers. 2020 Academic Article GET IT
Times cited: 12
Characterizing and classifying neuroendocrine neoplasms through microRNA sequencing and data mining. NAR cancer. 2020 Academic Article GET IT
Times cited: 15
Expression of the Receptor for Hyaluronic Acid-Mediated Motility (RHAMM) in Endometrial Cancer is Associated With Adverse Histologic Parameters and Tumor Progression. Applied immunohistochemistry & molecular morphology : AIMM. 2020 Academic Article GET IT
Times cited: 12
Evaluating gastroenteropancreatic neuroendocrine tumors through microRNA sequencing. Endocrine-related cancer. 2019 Academic Article GET IT
Times cited: 16
Assessing colorectal cancer mismatch repair status in the modern era: a survey of current practices and re-evaluation of the role of microsatellite instability testing. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2018 Academic Article GET IT
Times cited: 12
Immunohistochemical analysis of RHAMM expression in normal and neoplastic human tissues: a cell cycle protein with distinctive expression in mitotic cells and testicular germ cells. Oncotarget. 2018 Academic Article GET IT
Times cited: 29
Beyond the Percentages of PD-L1-Positive Tumor Cells: Induced Versus Constitutive PD-L1 Expression in Primary and Metastatic Head and Neck Squamous Cell Carcinoma. Head and neck pathology. 2017 Academic Article GET IT
Times cited: 30
Bcl-xL promotes metastasis independent of its anti-apoptotic activity. Nature communications. 2016 Academic Article GET IT
Times cited: 72
A cautionary note on the immunohistochemical detection of BRAF v600e mutations in serrated lesions of the colon. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2015 Letter GET IT
Times cited: 3
Detection of cancer/testis antigens as a diagnostic tool in routine pathology practice. Oncoimmunology. 2014 Academic Article GET IT
Cancer-testis antigen expression in digestive tract carcinomas: frequent expression in esophageal squamous cell carcinoma and its precursor lesions. Cancer immunology research. 2013 Academic Article GET IT
Times cited: 22
Cancer-testis gene expression is associated with the methylenetetrahydrofolate reductase 677 C>T polymorphism in non-small cell lung carcinoma. BMC medical genetics. 2013 Academic Article GET IT
Times cited: 4
Association of oncofetal protein expression with clinical outcomes in patients with urothelial carcinoma of the bladder. The Journal of urology. 2013 Academic Article GET IT
Times cited: 17
Expression of cancer/testis (CT) antigens in squamous cell carcinoma of the head and neck: evaluation as markers of squamous dysplasia. Pathology, research and practice. 2013 Academic Article GET IT
Times cited: 12
The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer. PloS one. 2013 Academic Article GET IT
Times cited: 35
Chromosome X-encoded Cancer/Testis antigens are less frequently expressed in non-seminomatous germ cell tumors than in seminomas. Cancer immunity. 2013 Academic Article GET IT
Times cited: 6
Histopathologic changes in punctal stenosis. Ophthalmic plastic and reconstructive surgery. 2013 Academic Article GET IT
Times cited: 19
Effects of CT-Xp gene knock down in melanoma cell lines. Oncotarget. 2013 Academic Article GET IT
Tissue-specific cadherin CDH17 is a useful marker of gastrointestinal adenocarcinomas with higher sensitivity than CDX2. American journal of clinical pathology. 2012 Academic Article GET IT
Times cited: 58
MicroRNA expression aids the preoperative diagnosis of pancreatic ductal adenocarcinoma. Pancreas. 2012 Academic Article GET IT
Times cited: 53
The journey from autologous typing to SEREX, NY-ESO-1, and cancer/testis antigens. Cancer immunity. 2012 Academic Article GET IT
Times cited: 8
Chromosome X-encoded cancer/testis antigens show distinctive expression patterns in developing gonads and in testicular seminoma. Human reproduction (Oxford, England). 2011 Academic Article GET IT
Times cited: 32
Colon cancer associated transcript-1: a novel RNA expressed in malignant and pre-malignant human tissues. International journal of cancer. 2011 Academic Article GET IT
Times cited: 201
Multiple cancer/testis antigens are preferentially expressed in hormone-receptor negative and high-grade breast cancers. PloS one. 2011 Academic Article GET IT
Times cited: 83
Seromic profiling of ovarian and pancreatic cancer. Proceedings of the National Academy of Sciences of the United States of America. 2010 Academic Article GET IT
Times cited: 155
Expression of cancer testis antigen CT45 in classical Hodgkin lymphoma and other B-cell lymphomas. Proceedings of the National Academy of Sciences of the United States of America. 2010 Academic Article GET IT
Times cited: 37
Clonal relationship between closely approximated low-grade ductal and lobular lesions in the breast: a molecular study of 10 cases. American journal of clinical pathology. 2009 Academic Article GET IT
Times cited: 19
Identification of borderline thyroid tumors by gene expression array analysis. Cancer. 2009 Academic Article GET IT
Times cited: 35
Cancer/testis (CT) antigens: potential targets for immunotherapy. Cancer science. 2009 Review GET IT
Times cited: 419
CT-X antigen expression in human breast cancer. Proceedings of the National Academy of Sciences of the United States of America. 2009 Academic Article GET IT
Times cited: 94
Cancer/testis antigen CT45: analysis of mRNA and protein expression in human cancer. International journal of cancer. 2009 Academic Article GET IT
Times cited: 44
Clinical, pathologic, and molecular features of early-onset colorectal carcinoma. The American journal of surgical pathology. 2009 Academic Article GET IT
Times cited: 121
Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes. The Journal of urology. 2009 Academic Article GET IT
Times cited: 14
Combined small cell lung carcinomas: genotypic and immunophenotypic analysis of the separate morphologic components. American journal of clinical pathology. 2009 Academic Article GET IT
Times cited: 41
High-resolution photoacoustic imaging with focused laser and ultrasonic beams. Applied physics letters. 2009 Academic Article GET IT
Autoantibodies against cancer antigens. Methods in molecular biology (Clifton, N.J.). 2009 Academic Article GET IT
Times cited: 38
Genome-wide analysis of cancer/testis gene expression. Proceedings of the National Academy of Sciences of the United States of America. 2008 Academic Article GET IT
Times cited: 297
CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens. Nucleic acids research. 2008 Academic Article GET IT
Times cited: 314
Immunohistochemical and molecular features of sporadic and FAP-associated duodenal adenomas of the ampullary and nonampullary mucosa. The American journal of surgical pathology. 2008 Academic Article GET IT
Times cited: 30
MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2008 Academic Article GET IT
Times cited: 174
ECSA/DPPA2 is an embryo-cancer antigen that is coexpressed with cancer-testis antigens in non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2008 Academic Article GET IT
Times cited: 24
Distinct expression patterns of the immunogenic differentiation antigen NY-BR-1 in normal breast, testis and their malignant counterparts. International journal of cancer. 2008 Academic Article GET IT
Times cited: 15
Serrated polyps with "intermediate features" of sessile serrated polyp and microvesicular hyperplastic polyp: a practical approach to the classification of nondysplastic serrated polyps. The American journal of surgical pathology. 2008 Academic Article GET IT
Times cited: 36
Survivin as a useful adjunct marker for the grading of papillary urothelial carcinoma. Archives of pathology & laboratory medicine. 2008 Academic Article GET IT
Times cited: 26
p53 in esophageal adenocarcinoma: a critical reassessment of mutation frequency and identification of 72Arg as the dominant allele. International journal of oncology. 2007 Academic Article GET IT
Times cited: 17
PLAC1, a trophoblast-specific cell surface protein, is expressed in a range of human tumors and elicits spontaneous antibody responses. Cancer immunity. 2007 Academic Article GET IT
Times cited: 71
A comprehensive study of nondysplastic and dysplastic serrated polyps of the vermiform appendix. The American journal of surgical pathology. 2007 Academic Article GET IT
Times cited: 38
Filiform serrated adenomas: a clinicopathologic and immunophenotypic study of 18 cases. The American journal of surgical pathology. 2007 Academic Article GET IT
Times cited: 61
Gene fusions between TMPRSS2 and ETS family genes in prostate cancer: frequency and transcript variant analysis by RT-PCR and FISH on paraffin-embedded tissues. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2007 Academic Article GET IT
Times cited: 142
NY-ESO-1 protein expression in primary breast carcinoma and metastases: correlation with CD8+ T-cell and CD79a+ plasmacytic/B-cell infiltration. International journal of cancer. 2007 Academic Article GET IT
Times cited: 59
NY-BR-1 protein expression in breast carcinoma: a mammary gland differentiation antigen as target for cancer immunotherapy. Cancer immunology, immunotherapy : CII. 2007 Academic Article GET IT
Times cited: 39
NY-BR-1 is a differentiation antigen of the mammary gland. Applied immunohistochemistry & molecular morphology : AIMM. 2007 Academic Article GET IT
Times cited: 25
Assessment of CD4+ T cells specific for the tumor antigen SSX-1 in cancer-free individuals. Cancer immunology, immunotherapy : CII. 2006 Academic Article GET IT
Times cited: 7
Gene expression profiling separates chromophobe renal cell carcinoma from oncocytoma and identifies vesicular transport and cell junction proteins as differentially expressed genes. Clinical cancer research : an official journal of the American Association for Cancer Research. 2006 Academic Article GET IT
Times cited: 62
Physical interaction of two cancer-testis antigens, MAGE-C1 (CT7) and NY-ESO-1 (CT6). Cancer immunity. 2006 Academic Article GET IT
Times cited: 37
Diagnosis of renal tumors on needle biopsy specimens by histological and molecular analysis. The Journal of urology. 2006 Academic Article GET IT
Times cited: 64
Diagnostic usefulness of HBME1, galectin-3, CK19, and CITED1 and evaluation of their expression in encapsulated lesions with questionable features of papillary thyroid carcinoma. American journal of clinical pathology. 2006 Academic Article GET IT
Times cited: 110
Microarray analysis of thyroid nodule fine-needle aspirates accurately classifies benign and malignant lesions. The Journal of molecular diagnostics : JMD. 2006 Academic Article GET IT
Times cited: 55
Expression and immunogenicity of NY-ESO-1 in hepatocellular carcinoma. Journal of gastroenterology and hepatology. 2006 Academic Article GET IT
Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patients. Cancer immunology, immunotherapy : CII. 2006 Academic Article GET IT
Times cited: 15
Preferential nuclear and cytoplasmic NY-BR-1 protein expression in primary breast cancer and lymph node metastases. Clinical cancer research : an official journal of the American Association for Cancer Research. 2006 Academic Article GET IT
Times cited: 35
Generation of monoclonal antibodies to cancer/testis (CT) antigen CT10/MAGE-C2. Cancer immunity. 2006 Academic Article GET IT
Times cited: 35
Identification of a new cancer/testis gene family, CT47, among expressed multicopy genes on the human X chromosome. Genes, chromosomes & cancer. 2006 Academic Article GET IT
Times cited: 28
NY-ESO-1: review of an immunogenic tumor antigen. Advances in cancer research. 2006 Review GET IT
Times cited: 268
Humoral and cellular immune responses against the breast cancer antigen NY-BR-1: definition of two HLA-A2 restricted peptide epitopes. Cancer immunity. 2005 Academic Article GET IT
Times cited: 36
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proceedings of the National Academy of Sciences of the United States of America. 2005 Academic Article GET IT
Times cited: 2022
Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2005 Academic Article GET IT
Times cited: 284
Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2005 Academic Article GET IT
Times cited: 38
Cancer/testis antigens, gametogenesis and cancer. Nature reviews. Cancer. 2005 Review GET IT
Times cited: 1152
Identification of CT46/HORMAD1, an immunogenic cancer/testis antigen encoding a putative meiosis-related protein. Cancer immunity. 2005 Academic Article GET IT
Times cited: 67
Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters. Cancer. 2005 Academic Article GET IT
Times cited: 58
Identification of cancer/testis-antigen genes by massively parallel signature sequencing. Proceedings of the National Academy of Sciences of the United States of America. 2005 Academic Article GET IT
Times cited: 98
CD4+ T cell responses to SSX-4 in melanoma patients. Journal of immunology (Baltimore, Md. : 1950). 2005 Academic Article GET IT
Times cited: 19
Distinct but overlapping T helper epitopes in the 37-58 region of SSX-2. Clinical immunology (Orlando, Fla.). 2005 Academic Article GET IT
Times cited: 16
Quantitative real-time RT-PCR analysis of NY-ESO-1 and LAGE-1a mRNA expression in normal tissues and tumors, and correlation of the protein expression with the mRNA copy number. International journal of oncology. 2005 Academic Article GET IT
Times cited: 12
Recombinant NY-ESO-1 cancer antigen: production and purification under cGMP conditions. Preparative biochemistry & biotechnology. 2005 Academic Article GET IT
Times cited: 32
Serological analysis of expression cDNA libraries (SEREX): an immunoscreening technique for identifying immunogenic tumor antigens. Methods in molecular medicine. 2005 Academic Article GET IT
Times cited: 15
HLA-DP4 expression and immunity to NY-ESO-1: correlation and characterization of cytotoxic CD4+ CD25- CD8- T cell clones. Cancer immunity. 2004 Academic Article GET IT
Times cited: 13
Immunohistochemical and molecular analysis of human melanomas for expression of the human cancer-testis antigens NY-ESO-1 and LAGE-1. Clinical cancer research : an official journal of the American Association for Cancer Research. 2004 Academic Article GET IT
Times cited: 54
Real-Time, label-free monitoring of tumor antigen and serum antibody interactions. Journal of biochemical and biophysical methods. 2004 Academic Article GET IT
Times cited: 73
Identification of the gonad-specific anion transporter SLCO6A1 as a cancer/testis (CT) antigen expressed in human lung cancer. Cancer immunity. 2004 Academic Article GET IT
Times cited: 44
Cancer/testis antigen expression and autologous humoral immunity to NY-ESO-1 in gastric cancer. Cancer immunity. 2004 Academic Article GET IT
Times cited: 36
NY-ESO-1 expression and immunogenicity in esophageal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2004 Academic Article GET IT
Times cited: 55
IFN-gamma enables cross-presentation of exogenous protein antigen in human Langerhans cells by potentiating maturation. Proceedings of the National Academy of Sciences of the United States of America. 2004 Academic Article GET IT
Times cited: 36
The humoral immune response to head and neck cancer antigens as defined by the serological analysis of tumor antigens by recombinant cDNA expression cloning. Cancer immunity. 2004 Academic Article GET IT
Times cited: 21
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans. Proceedings of the National Academy of Sciences of the United States of America. 2004 Academic Article GET IT
Times cited: 390
Identification of an SSX-2 epitope presented by dendritic cells to circulating autologous CD4+ T cells. Journal of immunology (Baltimore, Md. : 1950). 2004 Academic Article GET IT
Times cited: 17
[Expression of multiple cancer-testis antigen genes in non-small cell lung cancer treated by chemotherapy prior surgery]. Zhonghua yi xue za zhi. 2004 Academic Article GET IT
Times cited: 7
NY-ESO-1 expression and immunogenicity in malignant and benign breast tumors. Cancer research. 2004 Academic Article GET IT
Times cited: 87
Vaccine-induced CD4+ T cell responses to MAGE-3 protein in lung cancer patients. Journal of immunology (Baltimore, Md. : 1950). 2004 Academic Article GET IT
Times cited: 159
Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer. Cancer immunity. 2003 Academic Article GET IT
Times cited: 64
Identification and characterization of mouse SSX genes: a multigene family on the X chromosome with restricted cancer/testis expression. Genomics. 2003 Academic Article GET IT
Times cited: 20
Antigen-specific immunity in neuroblastoma patients: antibody and T-cell recognition of NY-ESO-1 tumor antigen. Cancer research. 2003 Academic Article GET IT
Times cited: 56
SSX antigens as tumor vaccine targets in human sarcoma. Cancer immunity. 2003 Academic Article GET IT
Times cited: 22
Expression of cancer/testis (CT) antigens in lung cancer. Lung cancer (Amsterdam, Netherlands). 2003 Academic Article GET IT
Times cited: 107
NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer. Cancer research. 2003 Academic Article GET IT
Times cited: 199
NY-ESO-1 mRNA expression and immunogenicity in advanced prostate cancer. Cancer immunity. 2003 Academic Article GET IT
Times cited: 53
Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease. Cancer immunity. 2003 Academic Article GET IT
Times cited: 117
Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses. Proceedings of the National Academy of Sciences of the United States of America. 2003 Academic Article GET IT
Times cited: 188
Immunomic analysis of human sarcoma. Proceedings of the National Academy of Sciences of the United States of America. 2003 Academic Article GET IT
Times cited: 103
Cross-presentation of HLA class I epitopes from exogenous NY-ESO-1 polypeptides by nonprofessional APCs. Journal of immunology (Baltimore, Md. : 1950). 2003 Academic Article GET IT
Times cited: 48
The SSX gene family: characterization of 9 complete genes. International journal of cancer. 2002 Academic Article GET IT
Times cited: 102
Expression of cancer-testis genes in human hepatocellular carcinomas. Cancer immunity. 2002 Academic Article GET IT
Times cited: 2
Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51. Cancer immunity. 2002 Academic Article GET IT
Times cited: 1
A new member of the NY-ESO-1 gene family is ubiquitously expressed in somatic tissues and evolutionarily conserved. Gene. 2002 Academic Article GET IT
Times cited: 25
CD8(+) T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patients. Proceedings of the National Academy of Sciences of the United States of America. 2002 Academic Article GET IT
Times cited: 84
Urine antibody against human cancer antigen NY-ESO-1. Cancer immunity. 2002 Academic Article GET IT
Times cited: 1
Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets. Cancer research. 2002 Academic Article GET IT
Times cited: 168
Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum. Cancer immunity. 2002 Academic Article GET IT
Times cited: 30
CT7 (MAGE-C1) antigen expression in normal and neoplastic tissues. International journal of cancer. 2002 Academic Article GET IT
Times cited: 60
Identification of cancer/testis genes by database mining and mRNA expression analysis. International journal of cancer. 2002 Academic Article GET IT
Times cited: 118
Diagnostic Accuracy of Cervical Low-Grade Squamous Intraepithelial Lesions Is Improved With MIB-1 Immunostaining. The American journal of surgical pathology. 2002 Academic Article GET IT
Times cited: 80
Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen NY-ESO-1 but not MAGE-A1 or CT7. International journal of cancer. 2001 Academic Article GET IT
Times cited: 148
Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues. International journal of cancer. 2001 Academic Article GET IT
Times cited: 295
Ny-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor grade. Cancer research. 2001 Academic Article GET IT
Times cited: 112
Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression. Cancer immunity. 2001 Academic Article GET IT
Times cited: 154
Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library. Cancer research. 2001 Academic Article GET IT
Times cited: 118
Immunohistochemical and reverse transcription-polymerase chain reaction expression analysis of tyrosinase and microphthalmia-associated transcription factor in angiomyolipomas. Applied immunohistochemistry & molecular morphology : AIMM. 2001 Academic Article GET IT
Times cited: 20
Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers. Proceedings of the National Academy of Sciences of the United States of America. 2000 Academic Article GET IT
Times cited: 407
MIB-1 immunostaining is a beneficial adjunct test for accurate diagnosis of vulvar condyloma acuminatum. The American journal of surgical pathology. 2000 Academic Article GET IT
Times cited: 43
Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele. Proceedings of the National Academy of Sciences of the United States of America. 2000 Academic Article GET IT
Times cited: 99
Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours. British journal of cancer. 2000 Academic Article GET IT
Times cited: 125
Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL. Journal of immunology (Baltimore, Md. : 1950). 2000 Academic Article GET IT
Times cited: 136
Serological cloning of a melanocyte rab guanosine 5'-triphosphate-binding protein and a chromosome condensation protein from a melanoma complementary DNA library. Cancer research. 2000 Academic Article GET IT
Times cited: 71
Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. Proceedings of the National Academy of Sciences of the United States of America. 2000 Academic Article GET IT
Times cited: 366
Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer. Proceedings of the National Academy of Sciences of the United States of America. 2000 Academic Article GET IT
Times cited: 211
Expression of cancer-testis antigens in lung cancer: definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9. Cancer letters. 2000 Academic Article GET IT
Times cited: 111
CT10: a new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis. International journal of cancer. 2000 Academic Article GET IT
Times cited: 111
Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma. The Journal of experimental medicine. 2000 Academic Article GET IT
Times cited: 207
Expression of MAGE-antigens in normal tissues and cancer. International journal of cancer. 2000 Academic Article GET IT
Times cited: 187
SEREX analysis of gastric cancer antigens. Cancer chemotherapy and pharmacology. 2000 Academic Article GET IT
Times cited: 25
T311--an anti-tyrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin embedded tissues. Pathology, research and practice. 2000 Academic Article GET IT
Times cited: 62
Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene. Cancer research. 1999 Academic Article GET IT
Times cited: 110
Antigens recognized by autologous antibody in patients with renal-cell carcinoma. International journal of cancer. 1999 Academic Article GET IT
Times cited: 159
Identification of Cancer Antigens in Breast Cancer by the SEREX Expression Cloning Method. Breast cancer (Tokyo, Japan). 1999 Academic Article GET IT
Expression of melanocyte-associated markers gp-100 and Melan-A/MART-1 in angiomyolipomas. An immunohistochemical and rt-PCR analysis. Virchows Archiv : an international journal of pathology. 1999 Academic Article GET IT
Times cited: 44
Isoforms of the human PDZ-73 protein exhibit differential tissue expression. Biochimica et biophysica acta. 1999 Academic Article GET IT
Times cited: 36
Cancer-testis antigens: targets for cancer immunotherapy. The cancer journal from Scientific American. 1999 Comment GET IT
Times cited: 74
Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma. The American journal of surgical pathology. 1998 Academic Article GET IT
Times cited: 185
Expression of SSX genes in human tumors. International journal of cancer. 1998 Academic Article GET IT
Times cited: 149
Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library. Proceedings of the National Academy of Sciences of the United States of America. 1998 Academic Article GET IT
Times cited: 278
Characterization of human colon cancer antigens recognized by autologous antibodies. International journal of cancer. 1998 Academic Article GET IT
Times cited: 299
A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues. The American journal of surgical pathology. 1998 Academic Article GET IT
Times cited: 206
A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. The Journal of experimental medicine. 1998 Academic Article GET IT
Times cited: 638
New paths in human cancer serology. The Journal of experimental medicine. 1998 Comment GET IT
Times cited: 406
Human lung cancer antigens recognized by autologous antibodies: definition of a novel cDNA derived from the tumor suppressor gene locus on chromosome 3p21.3. Cancer research. 1998 Academic Article GET IT
Times cited: 111
Juvenile-onset recurrent respiratory papillomatosis involving the lung: A case report and review of the literature. Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society. 1998 Review GET IT
Times cited: 15
Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. The Journal of experimental medicine. 1998 Academic Article GET IT
Times cited: 658
Immunoreactivity for A103, an antibody to melan-A (Mart-1), in adrenocortical and other steroid tumors. The American journal of surgical pathology. 1998 Academic Article GET IT
Times cited: 187
MHC class I and II expression in prostate carcinoma and modulation by interferon-alpha and -gamma. The Prostate. 1997 Academic Article GET IT
Times cited: 72
SSX: a multigene family with several members transcribed in normal testis and human cancer. International journal of cancer. 1997 Academic Article GET IT
Times cited: 197
A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proceedings of the National Academy of Sciences of the United States of America. 1997 Academic Article GET IT
Times cited: 1134
Genomic cloning and localization of CTAG, a gene encoding an autoimmunogenic cancer-testis antigen NY-ESO-1, to human chromosome Xq28. Cytogenetics and cell genetics. 1997 Academic Article GET IT
Times cited: 83
Serological analysis of Melan-A(MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas. Proceedings of the National Academy of Sciences of the United States of America. 1996 Academic Article GET IT
Times cited: 189
Follicle-stimulating hormone receptor is expressed in human ovarian surface epithelium and fallopian tube. The American journal of pathology. 1996 Academic Article GET IT
Times cited: 166
Immunophenotyping of melanomas for tyrosinase: implications for vaccine development. Proceedings of the National Academy of Sciences of the United States of America. 1995 Academic Article GET IT
Times cited: 173
Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma. Proceedings of the National Academy of Sciences of the United States of America. 1995 Academic Article GET IT
Times cited: 228
The tumor protein MAGE-1 is located in the cytosol of human melanoma cells. Biochemical and biophysical research communications. 1994 Academic Article GET IT
Overexpression of p53 protein in squamous cell carcinomas of head and neck without apparent gene mutations. Diagnostic molecular pathology : the American journal of surgical pathology, part B. 1994 Academic Article GET IT
Times cited: 73
Clonality analysis of B-cell lymphoma in fresh-frozen and paraffin-embedded tissues: the effects of variable polymerase chain reaction parameters. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 1994 Academic Article GET IT
Times cited: 28
A mouse mutant p53 product recognized by CD4+ and CD8+ T cells. Proceedings of the National Academy of Sciences of the United States of America. 1994 Academic Article GET IT
Times cited: 162
Frameshift and nonsense p53 mutations in squamous-cell carcinoma of head and neck - non-reactivity with 3 anti-p53 monoclonal-antibodies. International journal of oncology. 1994 Academic Article GET IT
Identification of the MAGE-1 gene product by monoclonal and polyclonal antibodies. Proceedings of the National Academy of Sciences of the United States of America. 1994 Academic Article GET IT
Times cited: 82
HIV antigen and DNA in AIDS spinal cords correlate with macrophage infiltration but not with vacuolar myelopathy. Journal of neuropathology and experimental neurology. 1994 Academic Article GET IT
Times cited: 53
Polymerase chain reaction-based detection of B-cell monoclonality in cytologic specimens. Archives of pathology & laboratory medicine. 1993 Academic Article GET IT
Times cited: 16
Cytomegalovirus infection of renal allografts. Detection by polymerase chain reaction. Transplantation. 1992 Academic Article GET IT
Times cited: 29
Immunohistochemistry and gene rearrangement studies in the diagnosis of malignant lymphomas: a comparison of 152 cases. Human pathology. 1991 Academic Article GET IT
Times cited: 25
A 58-year-old Vietnamese woman with a 1-month history of an enlarging right infraclavicular mass. Clinical imaging. 1990 Conference Paper GET IT
Cerebellar degeneration-related antigen: a highly conserved neuroectodermal marker mapped to chromosomes X in human and mouse. Proceedings of the National Academy of Sciences of the United States of America. 1990 Academic Article GET IT
Times cited: 63
Characterization of a cDNA encoding a 34-kDa Purkinje neuron protein recognized by sera from patients with paraneoplastic cerebellar degeneration. Proceedings of the National Academy of Sciences of the United States of America. 1989 Academic Article GET IT
Times cited: 47
Influence of 5' flanking sequences on TL and H-2 expression in transfected L cells. Proceedings of the National Academy of Sciences of the United States of America. 1988 Academic Article GET IT
Times cited: 20
Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration. Proceedings of the National Academy of Sciences of the United States of America. 1987 Academic Article GET IT
Times cited: 157
5'-structural analysis of genes encoding polymorphic antigens of chemically induced tumors. Proceedings of the National Academy of Sciences of the United States of America. 1987 Academic Article GET IT
Times cited: 56
Thymus-leukemia (TL) antigens of the mouse. Analysis of TL mRNA and TL cDNA TL+ and TL- strains. The Journal of experimental medicine. 1985 Academic Article GET IT
Times cited: 39
Structural analysis of TL genes of the mouse. Proceedings of the National Academy of Sciences of the United States of America. 1985 Academic Article GET IT
Times cited: 57
Nuclear-cytoplasmic transport and VAI RNA-independent translation of influenza viral messenger RNAs in late adenovirus-infected cells. Cell. 1984 Academic Article GET IT
Times cited: 28

more ...

less ...

Research

Sort by

Co-investigator Network

Funding awarded

Receptor for hyaluronan-mediated motility isoform B (RHAMM B) in Pancreatic Cancer Metastasis awarded by National Cancer Institute Co-Investigator 2022 - 2027
missing activity Co-Investigator 2017 - 2023

more ...

less ...

Background

education and training

Ph.D., Cornell University 1985
B.M., National Taiwan University School of Medicine (Taiwan) 1981

Contact

full name

Yao-Tseng Chen

primary email

ytchen@med.cornell.edu

webpage

Clinical Profile

VIVO Weill Cornell Medical College

Yao-Tseng Chen Professor Emeritus of Pathology and Laboratory Medicine

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email

webpage